Home » NANOGEN NAMES ROBERT SALTMARSH CFO
NANOGEN NAMES ROBERT SALTMARSH CFO
Nanogen, developer of advanced diagnostic products, has announced the appointment of Robert Saltmarsh as CFO. Saltmarsh joined Nanogen as vice president of corporate development last September. In addition to participating in business development initiatives, he assumed oversight of all financial operations and investor relations for the company.
MENAFN (http://www.menafn.com/qn_news_story.asp?StoryId=CqD4xubWbmda3Cda4nZm)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct